- Non-pharmacological Therapy
- Hypnotherapy
- Cognitive Behavioural Therapy
- Medical Devices
- Other Non-pharmacological Therapy)
- Pharmacological Therapy
- Prescription Sleep Aids
- Over-The-Counter Sleep Aids
Insomnia Treatment Market size was valued at USD 4.53 billion in 2022 and is poised to grow at a CAGR of 4.4% from 2023-2029. One of the most popular ways to treat insomnia is with sleeping pills. Insomnia is a sleep disorder in which patients have trouble sleeping. The person has a difficult time falling asleep or staying asleep during the night, and wakes up exhausted and lethargic for several hours. Patients with chronic insomnia may benefit from prescription sleep aids. Depending on the severity of your ailment and any other health factors you may have, they can be used for a short or long period of time. These medications are sometimes used in conjunction with opioids as an alternate treatment. Treatment for Insomnia In hospitals, drugs are prescribed for the treatment of insomnia. They are administered to the patient before they go to sleep to help them relax and fall asleep quickly. It is especially important for persons who suffer from depression or anxiety disorders, as these conditions alter their sleeping patterns. In pharmacies, insomnia treatment medicines are used to treat a variety of diseases such as insomnia, sleep apnea, and others. It is also known as hypnotics or sedative-hypnotic drugs, and it promotes natural sleep by relaxing or drowsing people. Due to an increase in demand for certain treatments, there was an increase in supply.
Insomnia Treatment Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
4.4%
Largest Market
North-America
Fastest Growing Market
Asia Pacific
Insomnia Treatment Market Dynamics
During the projection period, growth is expected to be driven by increased demand for innovative treatment alternatives and rising prevalence. Over the projected period, positive results from the combination of devices and pharmaceuticals are expected to fuel revenue growth in the insomnia therapeutics market.
North-America got significant share
Insomnia Treatment Market Regional Analysis
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The insomnia treatment market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Insomnia Treatment Market Segmentation
By Type
By End User
- Hospitals
- Ambulatory Surgical Centres
- Homecare Settings
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa (MEA)
Frequently Asked Questions
The global insomnia treatment market size was valued at USD 4.53 billion in 2022
The insomnia treatment market key players are Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Insomnia Treatment Market Introduction |
| 2.1.Global Insomnia Treatment Market - Taxonomy |
| 2.2.Global Insomnia Treatment Market - Definitions |
| 2.2.1. By Type |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3.Global Insomnia Treatment Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Insomnia Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Insomnia Treatment Market By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Non-pharmacological Therapy |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Hypnotherapy |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Cognitive Behavioural Therapy |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Medical Devices |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Other Non-pharmacological Therapy) |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Pharmacological Therapy |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Prescription Sleep Aids |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Over-The-Counter Sleep Aids |
| 5.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 6.Global Insomnia Treatment Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ambulatory Surgical Centres |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Homecare Settings |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Insomnia Treatment Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Insomnia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Non-pharmacological Therapy |
| 8.1.2.Hypnotherapy |
| 8.1.3.Cognitive Behavioural Therapy |
| 8.1.4.Medical Devices |
| 8.1.5.Other Non-pharmacological Therapy) |
| 8.1.6.Pharmacological Therapy |
| 8.1.7.Prescription Sleep Aids |
| 8.1.8.Over-The-Counter Sleep Aids |
| 8.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Ambulatory Surgical Centres |
| 8.2.3.Homecare Settings |
| 8.2.4.Others |
| 8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Insomnia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Non-pharmacological Therapy |
| 9.1.2.Hypnotherapy |
| 9.1.3.Cognitive Behavioural Therapy |
| 9.1.4.Medical Devices |
| 9.1.5.Other Non-pharmacological Therapy) |
| 9.1.6.Pharmacological Therapy |
| 9.1.7.Prescription Sleep Aids |
| 9.1.8.Over-The-Counter Sleep Aids |
| 9.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Ambulatory Surgical Centres |
| 9.2.3.Homecare Settings |
| 9.2.4.Others |
| 9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Insomnia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Non-pharmacological Therapy |
| 10.1.2.Hypnotherapy |
| 10.1.3.Cognitive Behavioural Therapy |
| 10.1.4.Medical Devices |
| 10.1.5.Other Non-pharmacological Therapy) |
| 10.1.6.Pharmacological Therapy |
| 10.1.7.Prescription Sleep Aids |
| 10.1.8.Over-The-Counter Sleep Aids |
| 10.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Ambulatory Surgical Centres |
| 10.2.3.Homecare Settings |
| 10.2.4.Others |
| 10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Insomnia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Non-pharmacological Therapy |
| 11.1.2.Hypnotherapy |
| 11.1.3.Cognitive Behavioural Therapy |
| 11.1.4.Medical Devices |
| 11.1.5.Other Non-pharmacological Therapy) |
| 11.1.6.Pharmacological Therapy |
| 11.1.7.Prescription Sleep Aids |
| 11.1.8.Over-The-Counter Sleep Aids |
| 11.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Ambulatory Surgical Centres |
| 11.2.3.Homecare Settings |
| 11.2.4.Others |
| 11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Insomnia Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Non-pharmacological Therapy |
| 12.1.2.Hypnotherapy |
| 12.1.3.Cognitive Behavioural Therapy |
| 12.1.4.Medical Devices |
| 12.1.5.Other Non-pharmacological Therapy) |
| 12.1.6.Pharmacological Therapy |
| 12.1.7.Prescription Sleep Aids |
| 12.1.8.Over-The-Counter Sleep Aids |
| 12.2. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Ambulatory Surgical Centres |
| 12.2.3.Homecare Settings |
| 12.2.4.Others |
| 12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Meda Consumer Healthcare Inc. (U.S.) |
| 13.2.2.Eisai Co Ltd. (Japan) |
| 13.2.3.Merck & Co., Inc. (U.S.) |
| 13.2.4.Pfizer, Inc. (U.S.) |
| 13.2.5.Pernix Therapeutics Holdings (U.S.) |
| 13.2.6.Sanofi S.A. (France) |
| 13.2.7.Vanda Pharmaceuticals, Inc (U.S.) |
| 13.2.8.Takeda Pharmaceutical Company Ltd. (Japan) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Meda Consumer Healthcare Inc. (U.S.)
- Eisai Co Ltd. (Japan)
- Merck & Co., Inc. (U.S.)
- Pfizer, Inc. (U.S.)
- Pernix Therapeutics Holdings (U.S.)
- Sanofi S.A. (France)
- Vanda Pharmaceuticals, Inc (U.S.)
- Takeda Pharmaceutical Company Ltd. (Japan)